MNPR
Monopar Therapeutics Inc

3,345
Mkt Cap
$467.78M
Volume
290,865.00
52W High
$105.00
52W Low
$26.06
PE Ratio
-20.45
MNPR Fundamentals
Price
$70.32
Prev Close
$70.00
Open
$70.00
50D MA
$74.80
Beta
1.45
Avg. Volume
262,075.73
EPS (Annual)
-$4.11
P/B
3.31
Rev/Employee
$0.00
Loading...
Loading...
News
all
press releases
Monopar Therapeutics Inc. (NASDAQ:MNPR) Short Interest Up 28.3% in December
Monopar Therapeutics Inc. (NASDAQ:MNPR - Get Free Report) saw a large growth in short interest during the month of December. As of December 31st, there was short interest totaling 1,056,017 shares, a...
MarketBeat·2d ago
News Placeholder
More News
News Placeholder
Monopar Therapeutics (NASDAQ:MNPR) CFO Quan Anh Vu Acquires 1,500 Shares
Monopar Therapeutics Inc. (NASDAQ:MNPR - Get Free Report) CFO Quan Anh Vu bought 1,500 shares of Monopar Therapeutics stock in a transaction dated Friday, December 26th. The stock was acquired at an...
MarketBeat·22d ago
News Placeholder
Monopar Therapeutics (NASDAQ:MNPR) CFO Purchases 1,500 Shares
Monopar Therapeutics Inc. (NASDAQ:MNPR - Get Free Report) CFO Quan Anh Vu purchased 1,500 shares of the business's stock in a transaction dated Friday, December 26th. The shares were purchased at an...
MarketBeat·23d ago
News Placeholder
Monopar Therapeutics Inc. (NASDAQ:MNPR) Short Interest Update
Monopar Therapeutics Inc. (NASDAQ:MNPR - Get Free Report) was the recipient of a significant growth in short interest during the month of December. As of December 15th, there was short interest...
MarketBeat·24d ago
News Placeholder
What Awaits These 4 Biotech Stocks That More Than Doubled in 2025
IONS, GPCR, MNPR and KOD more than double in 2025 as policy clarity, M&A revival and clinical wins lift biotech momentum into 2026.
Zacks·30d ago
News Placeholder
Monopar Therapeutics Inc. (NASDAQ:MNPR) Given Average Recommendation of "Buy" by Brokerages
Monopar Therapeutics Inc. (NASDAQ:MNPR - Get Free Report) has earned a consensus recommendation of "Buy" from the thirteen brokerages that are covering the firm, Marketbeat reports. One analyst has...
MarketBeat·1mo ago
News Placeholder
Monopar Therapeutics (NASDAQ:MNPR) Upgraded at Wall Street Zen
Wall Street Zen upgraded shares of Monopar Therapeutics from a "sell" rating to a "hold" rating in a report on Sunday...
MarketBeat·1mo ago
News Placeholder
Monopar Therapeutics (NASDAQ:MNPR) Shares Up 6.3% - Should You Buy?
Monopar Therapeutics (NASDAQ:MNPR) Trading Up 6.3% - Still a Buy...
MarketBeat·2mo ago
News Placeholder
Monopar Therapeutics (NASDAQ:MNPR) Downgraded to Sell Rating by Wall Street Zen
Wall Street Zen cut Monopar Therapeutics from a "hold" rating to a "sell" rating in a research note on Saturday...
MarketBeat·2mo ago
News Placeholder
Monopar Therapeutics (NASDAQ:MNPR) Shares Down 4% - Time to Sell?
Monopar Therapeutics (NASDAQ:MNPR) Stock Price Down 4% - What's Next...
MarketBeat·2mo ago
<
1
2
...
>

Latest MNPR News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.